Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old

Phase 4 Unknown 20000 enrolled Beijing Chaoyang District Centre for Disease Control and Prevention

NaSingle-groupOpen-labelPrevention

Summary

This phase IV clinical study evaluates the safety of enterovirus 71 vaccine in children aged 6-35 months old by the method of both passive and active surveillance.

Timeline

Start: 2016-07
Primary completion: 2018-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	enterovirus 71 vaccine	Vaccine	—	—

Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old

Summary

Timeline

Drugs

Indications